Brandon’s first #psoriasis flare-up didn’t occur until he was 24. Fortunately, Brandon’s #dermatology care team found a treatment that works for him. Read Brandon’s story in USA TODAY: https://bit.ly/3z1yugj
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)
Biotechnology Research
Westlake Village, California 21,317 followers
Bioscience, applied to the skin.
About us
Arcutis (Nasdaq: ARQT) was founded in 2016 to address significant unmet needs in medical dermatology. The company is an early commercial stage biopharmaceutical company focused on developing and commercializing best-in-class products. Our strategy is to exploit recent innovations in inflammation and immunology to bring the best molecules to bear against validated physiologic targets known to treat dermatological diseases and disorders. Our management team has extensive expertise in the development and commercialization of medical dermatology products, having held key leadership roles at a number of leading dermatology companies and, collectively, has successfully developed more than 50 FDA-approved products. We believe that by leveraging our team’s unique experience and demonstrated expertise to identify, develop and commercialize best-in-class molecules against validated targets, we will be able to develop differentiated products in less time, at lower cost, and at substantially lower risk than other approaches. Arcutis' combination of vision, unmet medical need, experienced management and strategic approach has attracted support from leading investors in the life sciences sector.
- Website
-
http://www.arcutis.com
External link for Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Westlake Village, California
- Type
- Public Company
- Founded
- 2016
- Specialties
- Biotechnology, Medical Dermatology, Drug Development, Inflammation, Immunology, Clinical Trials, Topical Drugs, Bioscience, Commercialization, Plaque Psoriasis, Atopic Dermatitis, and Eczema
Locations
-
Primary
2945 Townsgate Rd
Westlake Village, California 91361, US
Employees at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)
-
Jana Jarvis
Executive Director, Program Management at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)
-
Frank Watanabe
-
Amanda Sheldon
Healthcare Communications Leader | Building Engagement through Storytelling | Digital & Social | Master Crafter
-
Ryan Souders
Arcutis Biotherapeutics Associate General Counsel
Updates
-
This morning, we proudly rang the Nasdaq Exchange opening bell, celebrating our most recent commercial launch in #eczema. A heartfelt thank you to our team and all those who helped us reach this milestone. Watch a replay of the ceremony: https://lnkd.in/gQVcT7ir $ARQT #CompanyMilestone
-
#NEWS: Today, we announced the enrollment of the last subject in a Phase 1b #clinicaltrial evaluating our investigational treatment in #alopeciaareata. Learn more: https://lnkd.in/daei6xfy #ClinicalDermatology #Dermatology $ARQT
-
We’re looking forward to attending the Morgan Stanley Global Healthcare Conference, where President and CEO, Frank Watanabe will host a fireside chat. Details below. #ClinicalDermatology $ARQT
-
We hope stories like Samantha’s will encourage others living with #psoriasis to seek help and keep living life to the fullest. We’re committed to meeting the urgent needs of people living with psoriasis. Learn about our approach to meaningful innovation: https://bit.ly/4czuNgd #PsoriasisActionMonth #PatientStory #Dermatology #ClinicalDermatology
-
#NEWS: Today, we announced results from the study of our topical, steroid-free cream for #AtopicDermatitis in children aged 2-5. Learn about results from the INTEGUMENT-OLE long-term open-label study: https://bit.ly/4dYzrEF #ClinicalDermatology #Dermatology $ARQT
-
This month we are highlighting Executive Director of Market Access, Allison Stewart, who shows up every day and embodies our team values and company mission. Thank you, Allison! #ThisIsArcutUS
-
It took nearly 20 years for Reena to share her #psoriasis journey with the world. Now, she uses her platform to encourage others living with psoriasis to find support and feel confident in their skin. In honor of #PsoriasisActionMonth, take a moment to learn about psoriasis: https://bit.ly/4cYz5O8 #PatientStory #Dermatology #ClinicalDermatology
-
Our approach to advancing meaningful innovation is powered by an understanding of what matters to those living with serious #skindiseases, their caregivers, and #dermatology providers. David Berk, MD, FAAD, Vice President of R&D Strategy, shares more in the video below. #ClinicalDermatology #ThisIsArcutUS #Innovation #MedEd
-
#NEWS: Today, we are pleased to announce our strong #Q2 2024 financial results and provide an update on the growth of product portfolio sales. Read our release for full details: https://bit.ly/4cHBw7f $ARQT